1.Expert Panel on Gastrointestinal Imaging, Arif-Tiwari H, Porter KK, et al.ACR Appropriateness Criteria® Abnormal Liver Function Tests. J Am Coll Radiol.2023;20(11S):S302-S314.doi:10.1016/j.jacr.2023.08.023

2.Pisano M, Allievi N, Gurusamy K, et al.2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World J Emerg Surg.2020;15(1):61.Published 2020 Nov 5.doi:10.1186/s13017-020-00336-x

3.Wu X, Li K, Kou S, Wu X, Zhang Z.The Accuracy of Point-of-Care Ultrasound in the Detection of Gallbladder Disease: A Meta-analysis. Acad Radiol.2024;31(4):1336-1343.doi:10.1016/j.acra.2023.09.029

4.Gurusamy KS, Giljaca V, Takwoingi Y, et al.Ultrasound versus liver function tests for diagnosis of common bile duct stones.Cochrane Database Syst Rev.2015(2):CD011548, 2015.doi: 10.1002/14651858.CD011548

5.Frenette C, Mendiratta-Lala M, Salgia R, Wong RJ, Sauer BG, Pillai A.ACG Clinical Guideline: Focal Liver Lesions. Am J Gastroenterol.2024;119(7):1235-1271.doi:10.14309/ajg.0000000000002857

6.Freitas PS, Janicas C, Veiga J, et al.Imaging evaluation of the liver in oncology patients: A comparison of techniques.World J Hepatol.13(12):1936-1955, 2021.doi: 10.4254/wjh.v13.i12.1936

7.Panagiotopoulos N, Wolfson T, Harris DT, et al.Proton density fat fraction for diagnosis of metabolic dysfunction-associated steatotic liver disease. Hepatology.Published online March 25, 2025.doi:10.1097/HEP.0000000000001318

8.Sterling RK, Duarte-Rojo A, Patel K, et al.AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology.2025;81(2):672-724.doi:10.1097/HEP.0000000000000843

9.Soto JA, Alvarez O, Múnera F, Velez SM, Valencia J, Ramírez N.Diagnosing bile duct stones: comparison of unenhanced helical CT, oral contrast-enhanced CT cholangiography, and MR cholangiography. AJR Am J Roentgenol. 2000;175(4):1127-1134.doi:10.2214/ajr.175.4.1751127

10.Chiorean EG, Chiaro MD, Tempero MA, et al.Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw.2023;21(7):753-782.doi:10.6004/jnccn.2023.0034

11.Barakat M, Saumoy M, Forbes N, Elmunzer BJ.Complications of Endoscopic Retrograde Cholangiopancreatography. Gastroenterology. 2025;169(2):230-243.e8.doi:10.1053/j.gastro.2025.03.009

12.ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al.Adverse events associated with ERCP. Gastrointest Endosc.2017;85(1):32-47.doi:10.1016/j.gie.2016.06.051

13.Yaghoobi M, Pauls Q, Durkalski V, et al.Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study. Endoscopy. 2015;47(10):884-890.doi:10.1055/s-0034-1392418

14.Tenner S, Vege SS, Sheth SG, et al.American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. Am J Gastroenterol.2024;119(3):419-437.doi:10.14309/ajg.0000000000002645

15.Bishay K, Meng ZW, Khan R, et al.Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis. Gastroenterology. 2025;168(3):568-586.doi:10.1053/j.gastro.2024.10.033

16.Pang L, Wu S, Kong J.Comparison of Efficacy and Safety between Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangial Drainage for the Treatment of Malignant Obstructive Jaundice: A Systematic Review and Meta-Analysis. Digestion.2023;104(2):85-96.doi:10.1159/000528020

17.Bian C, Fang Y, Xia J, et al.Is percutaneous drainage better than endoscopic drainage in the management of patients with malignant obstructive jaundice?A meta-analysis of RCTs. Front Oncol. 2023;13:1105728.Published 2023 Jan 30.doi:10.3389/fonc.2023.1105728